Standardizing Terminology and Assessment for Orofacial Conditions in Juvenile Idiopathic Arthritis: International, Multidisciplinary Consensus-based Recommendations by Stoustrup, Peter et al.
This is a pre-copyediting, author-produced PDF of an article accepted for publication in The Journal of 
Rheumatology following peer review. The definitive publisher-authenticated version J Rheumatol. 2019 
May;46(5):518-522 is available online at: http://www.jrheum.org/content/46/5/518. 
 
Standardizing Terminology and Assessment for Orofacial Conditions in 
Juvenile Idiopathic Arthritis: International, Multidisciplinary Consensus-
based Recommendations 
 
Authors: Peter Stoustrup1*, Cory M. Resnick2, Thomas Klit Pedersen3, Shelly Abramowicz4, 
Ambra Michelotti5, Annelise Küseler6, Carlalberta Verna7, Christian J Kellenberger8, Ellen Berit 
Nordal9, Giuliana Caserta10, Iveta Jankovska11 , Josefine Mareile Halbig12, Kasper Dahl 
Kristensen13, Linda Z Arvidsson14, Lynn Spiegel15, Mathew L Stoll16, Melissa Lerman17, Mia 
Glerup18, Patrizia Defabianis19, Paula Frid20, Per Alstergren21, Randy Q Cron22, Sarah Ringold23, 
Sven Erik Nørholt24, Timo Peltomäki25, Troels Herlin26, Zachary S Peacock27,  Marinka Twilt28 on 
behalf of the TMJ Juvenile Arthritis Working group (TMJaw).  
 
1 Associate Professor of Orthodontics, Section of Orthodontics, Department of Dentistry and 
Oral Health, Aarhus University, Aarhus, Denmark  
2 Assistant Professor of Oral and Maxillofacial Surgery, Harvard School of Dental Medicine and 
Harvard Medical School, Boston, MA; Oral and Maxillofacial Surgeon, Department of Plastic 
and Oral Surgery, Boston Children’s Hospital, Boston, MA 
3 Consultant Orthodontist, Professor, PhD. Department of Oral and Maxillofacial Surgery, 
Aarhus University Hospital, Section of Orthodontics, Aarhus University, Denmark 
4 DMD, MPH, FACS, Associate Professor, Oral and Maxillofacial Surgery and Pediatrics, Emory 
University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, USA 
5 DDS, Orthod, Department of Neuroscience, Reproductive Sciences and Oral Sciences, 
Section of Orthodontics, University of Naples Federica II, Naples, Italy. 
6 DDS, PhD, Department of Orthodontics, Aarhus University Hospital, Aarhus, Denmark 
7 DDS, PhD, Professor and Head, Department of Orthodontics and Pediatric Dentistry, UZB, 
University Center for Dental Medicine, Basel, Switzerland 
8 MD, Prof. Dr. med., Department of Diagnostic Imaging, University Children’s Hospital Zurich, 
Switzerland. 
9 MD, PhD, Department of Pediatrics, University of North Norway and Department of Clinical 
Medicine, UIT the Artic University of Norway, Tromso, Norway 
10 DDS, lecturer, CIR- Dental School, Section of paediatric Dentistry, University of Turin, Italy. 
11 DDS, PhD, assistant professor, Department of Orthodontics, Faculty of Dentistry, Rigas 
Stradins University, Latvia 
12 Dr. med.dent, DDS, The public Dental Service Competence Centre of North Norway (TkNN), 
Norway 
13 DDS, PhD, Guest researcher, Section of Orthodontics, Department of Dentistry and Oral 
Health, Aarhus University, Aarhus, Denmark 
14 DDS, PhD, Associate Professor, Department of Maxillofacial Radiology, Institute of Clinical 
Dentistry, University of Oslo, Norway 
15 MD, FRCPC, Department of Pediatrics, Division of Rheumatology, The Hospital of Sick 
Children, University of Toronto, Toronto, Ontario, Canada 
16 MD, PhD, MSCS, University of Alabama at Birmingham, Birmingham, AL, USA 
17 MD, MSc, PhD, assistant Professor of clinical pediatrics, Perelman School of Medicine, 
University of Pennsylvania, and Children’s Hospital of Philadelphia, USA 
18 MD, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark. 
19 MD, DDS, Associated Professor, Chairman and Program Director of Pediatric Dentistry, 
Section of Pediatric Dentistry, CIR-Dental School, University of Turin, Italy. 
20 DDS, Department of Otorhinolaryngology, Division of Oral and Maxillofacial Surgery, 
University Hospital North Norway and Public Dental Service Competence Centre of North 
Norway and Department of Clinical Medicine, Faculty of Health Sciences, The Arctic University 
of Norway, Tromso, Norway 
21 DDS, PhD, Malmo University, Faculty of Odontology, Orofacial Pain Unit, Malmo and Skane 
University Hospital, Specialized Pain Rehabilitation, Lund, Sweden 
22 MD, PhD, University of Alabama at Birmingham, USA 
23 MD, MS, Seattle Children’s Hospital, Seattle, WA, USA 
24 DDS, PhD, Clinical Professor, Consultant Surgeon, Department of Oral and Maxillofacial 
Surgery, Aarhus University Hospital, and Section of Oral Surgery and Oral Pathology, Aarhus 
University. 
25 DDS, PhD, Department of Ear and Oral Diseases, Tampere University Hospital and Faculty of 
Medicine and Life Sciences, University of Tampere, and Institute of Dentistry and University of 
Eastern Finland, Kuopio, Finland 
26 MD, DMSci, Pediatric Rheumatology Clinic, Pediatrics and Adolescent Medicine, Aarhus 
University Hospital, Aarhus, Denmark. 
27 DMD, MD, Assistant Professor, Department of Oral and Maxillofacial Surgery, Massachusetts 
General Hospital and Harvard School of Dental Medicine, Boston, MA, USA 
28 MD, MSCE, PhD, Assistant professor, Department of Pediatrics, Cumming School of 







Objectives: To propose multidisciplinary, consensus-based, standardization of operational terminology 
and method-of-assessment for condition related to temporomandibular joint (TMJ) involvement in 
juvenile idiopathic arthritis (JIA). 
Methods: Using a sequential phased approach, an expert group defined terminology and methods-of-
assessment by: 1) establishment of task force, 2) item generation, 3) working-group consensus meeting 
with drafting of provisional recommendations, 4) content validity testing of provisional 
recommendations by external experts, and 5) two round Delphi survey to reach final consensus among 
multidisciplinary group of experts (n=30) representing pediatric rheumatology, maxillofacial surgery, 
orthodontics, pediatric dentistry, radiology, and orofacial pain.  
Results: A total of seven standardized operational terms were defined: TMJ arthritis, TMJ involvement, 
TMJ arthritis management, dentofacial anomaly, TMJ anomaly, TMJ symptoms, and TMJ dysfunction. All 
terms received a Delphi survey agreement score >80%. Additionally, the expert group defined methods-
of-assessment for each of the terms from a pre-specified list of options.    
Conclusions: The definition of seven operational standardized terms provides an optimal platform for 
communication across health care providers involved in TMJ arthritis management and will serve as 






Temporomandibular joint (TMJ) arthritis is common in juvenile idiopathic arthritis (JIA).[1, 2] TMJ 
arthritis may impair joint mobility and masticatory function, cause TMJ degeneration, lead to reduced 
dentofacial growth, create orofacial pain, and impact general quality of life.[3-8] Treatment is complex 
and multidisciplinary, involving pediatric rheumatologists, maxillofacial surgeons, orthodontists, 
radiologists, pediatric dentists, occupational and physiotherapists, and orofacial pain specialists.[9]  
Research in TMJ arthritis has increased exponentially over the last decade. As this field has grown, so 
has confusion over terminology. Recent systematic reviews have highlighted the need for a standardized 
set of JIA-associated TMJ arthritis definitions.[6-8] Standardization is critical to enhance research 
comparability and care provider communication.  
The objectives of this study were to use a consensus-based approach to propose: 1) a standardized 
terminology for JIA-associated TMJ arthritis, and 2) methods of assessment of TMJ arthritis in patients 
with JIA.  
 
Materials and Methods 
 
This study was conducted using a series of sequential iterations including: 1) establishment of task force 
and item generation, 2) working-group consensus meeting and drafting of provisional 
recommendations, 3) content validity testing of provisional recommendations by external experts, 4) 
Delphi survey to reach final consensus (Figure 1). 
 
Task force assembly, item generation, consensus-meeting  
The task force was assembled with members of the TMJ Juvenile Arthritis Working group (TMJaw; 
formerly known as euroTMjoint research network), an international, multidisciplinary, open group 
studying TMJ arthritis in JIA, and includes researchers from all specialties involved in JIA-related TMJ 
arthritis management. Members of the terminology task force were identified based on clinical 
experience and scientific contributions. The task force included one pediatric rheumatologist (MT), two 
oral maxillofacial surgeons (SA, CR) and two orthodontists (TKP, PS), and represents one European and 
three North American centers.  
For item generation, the task force identified TMJ arthritis-related terms used in existing JIA 
literature.[7, 8] In February 2017, those terms were distributed to all members of TMJaw via email, with 
an invitation to participate in an online questionnaire. The participants were asked to report their 
understanding of these terms and the role of different specialties involved in TMJ arthritis management.  
Based on the results of the online questionnaire, the terminology task force generated six provisional 
terms for discussion at the TMJaw meeting in Rostock, Germany, March 2017. The provisional terms 
were adjusted and definitions for each term were established based on consensus from the group.  
 
Test of face validity 
In April 2017, 16 external experts were invited to assess the validity of the provisional terms and 
definitions generated at the Rostock consensus-meeting. The external experts were identified based on 
TMJ arthritis clinical expertise and scientific merit. The external experts were asked to assess validity, 
suggest improvements, and address redundancies for the provisional terms. The task force then 
adjusted the provisional terms and definitions accordingly.  
 
Delphi survey 
In September 2017, participants from the Rostock consensus-meeting (n=18) and external experts 
(n=16) were invited to participate in an online Delphi survey to assess agreement with the provisional 
terms. Participants were asked to respond to each term and definition with: “agree”, “agree with minor 
changes”, “do not agree”. Participants were also asked to suggest improvements to the terms and 
definitions, and to define methods-of-assessment for each term from the following options: 1) contrast-
enhanced magnetic resonance imaging (MRI), 2) MRI without contrast, 3) 3-dimensional (3D) imaging 
(e.g., computed tomography or cone-beam computed tomography), 4) conventional radiology (e.g., 
cephalograms and panoramic radiographs), 5) ultrasonography, 6) clinical examination, 7) patient 
reported outcomes, 8) other (e.g., 3D photographs and scintigraphy). Participants could select multiple 
options.   
The provisional terms and definitions were adjusted based on the results of this Delphi survey. These 
results were provided to participants before initiation of the next iteration in December 2017. In this 
final Delphi round, participants could “agree” or “disagree” with each term and definition. Only terms 
and definitions that received “agreement” by >80% of participants were included in the final 
recommendations. The results were summarized, and final consensus was reached in February 2018.  
 
Results 
Thirty experts participated in the final Delphi survey (Table 1). The following specialties were 
represented: pediatric rheumatology (n=10), maxillofacial surgery (n=5), orthodontics (n=8), pediatric 
dentistry (n=3), radiology (n=3), orofacial pain (n=1). Based on results of the first round of the Delphi 
survey, the number of terms was expanded from six to seven; the term “TMJ disability” was divided into 
“TMJ symptoms” and “TMJ dysfunction”. All seven provisional terms received a Delphi survey 
agreement score >80%.  
TMJ arthritis 
Arthritis is defined as “inflammation in a joint”. The term “TMJ arthritis”, therefore, is intended to 
indicate the presence of TMJ inflammation, and is independent of signs and symptoms. To add the 
qualifier “active” to the definition was considered redundant by some, but this word was ultimately 
included to highlight the strict nature of the term, which refers only to inflammation and not joint 
damage per se. The term “chronic” TMJ arthritis has been used in literature, but the task force 
recommends avoiding this term due to imprecision. 
Contrast-enhanced MRI is the current method for assessment of active inflammation in TMJ arthritis.[7] 
Other methods (e.g., clinical examination and patient reporting) may suggest the presence of TMJ 
arthritis, but cannot confirm the presence of inflammation. Contrast-enhanced MRI was the only 
method-of-assessment that received a recommendation score >80%. A recently published MRI scoring 
system is recommended.[10, 11]  
 
 
TMJ involvement and TMJ arthritis management 
“TMJ involvement” is defined as “abnormalities presumed to be the result of TMJ arthritis”. This term is 
less restrictive than “TMJ arthritis”. The presence of active TMJ inflammation (“TMJ arthritis”) is not a 
prerequisite for “TMJ involvement”, but “TMJ arthritis” implies the presence of “TMJ involvement”. The 
term “TMJ involvement” is intended for:  1) clinical situations in which no contrast-enhanced MRI 
verification of active TMJ inflammation has occurred, but where signs, symptoms and/or radiological 
findings suggest the presence of actual or former TMJ arthritis; 2) patients with no current MRI evidence 
of active TMJ inflammation (“TMJ arthritis) but with abnormalities indicating previous TMJ arthritis. 
Once the TMJ has been inflamed, it is prospectively considered “involved” regardless of the current 
inflammatory state.  
By definition, “TMJ arthritis management” embraces diagnosis, treatment, and monitoring of TMJ 
arthritis and involvement. Methods-of-assessment include contrast-enhanced MRI, 3D imaging, clinical 
examination, and patient-reported outcomes. 
 
Dentofacial anomaly and TMJ anomaly 
“Dentofacial anomaly” refers to growth deviation that occurs as a result of TMJ arthritis in patients with 
JIA. Growth deviation may affect the morphology and position of the mandible, maxilla, and/or dental 
occlusion.[12, 13] The recommended assessment of dentofacial anomaly includes 3D imaging, 
conventional radiography, clinical examination and photographs, and recent recommendations are 
available.[13] 
 “TMJ anomaly” indicates arthritis-related alteration of the anatomy of the TMJ. This term does not 
cover signs and symptoms (which are considered in a future term, “TMJ dysfunction”), but rather is 
limited to anatomic anomalies. 3D imaging and conventional radiographs are used to assess osseous 
TMJ anomalies, with the caveat that soft tissue changes, which are often present in TMJ anomalies, will 
not be visible with these imaging techniques but would require MRI evaluation.  
 
TMJ symptoms and TMJ dysfunction 
“TMJ symptoms” refers to patient/parent reported measures. In contrast, the term “TMJ dysfunction” 
addresses clinical examination signs of abnormal mandibular function believed to be related to TMJ 
involvement. Recent recommendations for clinical orofacial examination in JIA are available.[8] The final 
recommendations for standardized terminology and definitions are presented in Table 1. The final 




In this study, the TMJaw group has described and defined the most common terms used in TMJ arthritis 
research and is uniquely positioned to provide these recommendations for standardization of 
terminology representing multiple specialties and many North American and European TMJ arthritis 
research centers. Consensus-based standardization of terminology provides an optimal platform for 
communication across health care providers involved in research and management of TMJ arthritis in 
JIA. An important qualifier is that these terms only apply to JIA patients. It must be noted that TMJ 
symptoms and/or TMJ dysfunction may not be directly attributable to JIA, as in a patient with myofascial 
pain disorder. At this point, no reliable diagnostic method exists to distinguish between JIA-related 
orofacial symptoms/dysfunction and similar findings due to other etiologies. This project did not intend 
to define terms applicable to other temporomandibular dysfunction; further studies are required. 
Additionally, the methods-of-assessment that received recommendation scores >80% represent the 
most frequent diagnostic measures used to assess each term, and serve as a guide. Methods-of-
assessment with a recommendation score <80% should not be discounted, however, as they may still be 
useful in special clinical scenarios.  
The unequal numbers of participating experts representing different specialties may be a limitation to 
this study, however we are convinced that it strengthens the recommendations that so many different 
experts agree on the proposed standardized terminology. 
 
We encourage investigators and clinicians to use the recommended terms and definitions in future 
publications as a reference standard. We suggest to include the following text: “terminology adheres to 
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Table 1. Recommended standardized operational terminology, definitions and agreement with definitions. 
The terminology applies to subjects with a diagnosis of juvenile idiopathic arthritis. TMJ, 
temporomandibular joint.  
Term Definition Agreement with 
definition 
TMJ arthritis Active inflammation in the TMJ 100% 
TMJ involvement Abnormalities presumed to be the result of TMJ arthritis 90% 
TMJ arthritis management Diagnosis, treatment and monitoring of TMJ arthritis and 
involvement 
100% 
Dentofacial anomaly Abnormality in growth, development, structure and/or 
alignment of the facial bones and dentition 
93% 
TMJ anomaly Abnormality in growth, development or structure of the 
osseous and/or soft-tissue components of the TMJ 
90% 
TMJ symptoms Patient or parent-reported conditions related to TMJ 
arthritis or involvement 
93% 
TMJ dysfunction Physician-reported functional examination abnormalities 








Table 2. Standardized terminology and method-of-assessment. Specific method of assessment are 
recommended when expert assessment ≥80%. Method-of-assessment with a recommendation score <80% 
should not be discounted as they may still be important in special situations. * “Others” represent 3D 
photography and clinical photos. **Scintigraphy was included as an option to assess “TMJ anomaly” in the 
second Delphi-round and was recommended by 28% of the participants. TMJ, temporomandibular joint.  
 
 

















TMJ arthritis 100% 7% 0% 3% 13% 29% 23% 0% 
TMJ involvement 87% 43% 83% 67% 20% 83% 57% 13% 
TMJ arthritis 
management 
93% 35% 90% 69% 41% 93% 90% 17% 
Dentofacial anomaly 35% 31% 97% 90% 14% 97% 28% 86%* 
TMJ anomaly 62% 59% 100% 86% 28% 83% 24% 7%** 
TMJ symptoms 18% 14% 14% 7% 7% 59% 100% 7% 
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